Wangli AI Therapy Secures Class III Approval
💡China's 1st AI depression app gets med approval + funding; model mental health AI opps
⚡ 30-Second TL;DR
What Changed
B+ round funding of tens of millions led by Yuan Yi Capital
Why It Matters
Paves way for AI-driven mental health commercialization in China, boosting hospital adoption and patient access. Signals regulatory maturity for digital therapeutics.
What To Do Next
Test WonderLab's JITAI algorithms on mental health datasets for personalized intervention benchmarks.
Key Points
- •B+ round funding of tens of millions led by Yuan Yi Capital
- •WL-iCBT approved as China's first Class III med device for depression
- •WonderLab LLM integrates CBT/ACT with RL and JITAI for personalized therapy
- •30万 patient data database and 10+ papers in top journals
- •Recommended in 2025 China Depression Guidelines as 1A treatment
Weekly AI Recap
Read this week's curated digest of top AI events →
👉Related Updates
AI-curated news aggregator. All content rights belong to original publishers.
Original source: 36氪 ↗
This is a summary, not the original. Read the source, or get the weekly briefing.
Weekly AI briefing
One email a week. Unsubscribe anytime.